Xie F - Search Results

1

Bioprinting of patient-derived in vitro intrahepatic cholangiocarcinoma tumor model: establishment, evaluation and anti-cancer drug testing.

Mao S, He J, Zhao Y, Liu T, Xie F, Yang H, Mao Y, Pang Y, Sun W. Mao S, et al. Among authors: xie f. Biofabrication. 2020 Jul 29;12(4):045014. doi: 10.1088/1758-5090/aba0c3. Biofabrication. 2020. PMID: 32599574

2

The first-line treatment for unresectable hepatocellular carcinoma patients: lenvatinib versus sorafenib, or beyond?

Xie F, Feng S, Sun L, Mao Y. Xie F, et al. Hepatobiliary Surg Nutr. 2018 Jun;7(3):221-224. doi: 10.21037/hbsn.2018.06.06. Hepatobiliary Surg Nutr. 2018. PMID: 30046580 Free PMC article. No abstract available.

3

Extracellular vesicles in hepatocellular cancer and cholangiocarcinoma.

Xie F, Feng S, Yang H, Mao Y. Xie F, et al. Ann Transl Med. 2019 Mar;7(5):86. doi: 10.21037/atm.2019.01.12. Ann Transl Med. 2019. PMID: 31019936 Free PMC article. No abstract available.

4

Alcohol consumption as a cause of cancer: urging for more mechanism study.

Xie F, Feng S, Mao Y. Xie F, et al. Hepatobiliary Surg Nutr. 2019 Jun;8(3):318-320. doi: 10.21037/hbsn.2019.01.20. Hepatobiliary Surg Nutr. 2019. PMID: 31245426 Free PMC article. No abstract available.

5

The Clinicopathological and Prognostic Value of PD-L1 Expression in Cholangiocarcinoma: A Meta-Analysis.

Xu G, Sun L, Li Y, Xie F, Zhou X, Yang H, Du S, Xu H, Mao Y. Xu G, et al. Among authors: xie f. Front Oncol. 2019 Sep 18;9:897. doi: 10.3389/fonc.2019.00897. eCollection 2019. Front Oncol. 2019. PMID: 31620360 Free PMC article.

6

Albumin binding function is a novel biomarker for early liver damage and disease progression in non-alcoholic fatty liver disease.

Sun L, Wang Q, Liu M, Xu G, Yin H, Wang D, Xie F, Jin B, Jin Y, Yang H, Zhou J, Mao Y. Sun L, et al. Among authors: xie f. Endocrine. 2020 Aug;69(2):294-302. doi: 10.1007/s12020-020-02319-z. Epub 2020 May 12. Endocrine. 2020. PMID: 32399892

7

Application of a 3D Bioprinted Hepatocellular Carcinoma Cell Model in Antitumor Drug Research.

Sun L, Yang H, Wang Y, Zhang X, Jin B, Xie F, Jin Y, Pang Y, Zhao H, Lu X, Sang X, Zhang H, Lin F, Sun W, Huang P, Mao Y. Sun L, et al. Among authors: xie f. Front Oncol. 2020 Jun 3;10:878. doi: 10.3389/fonc.2020.00878. eCollection 2020. Front Oncol. 2020. PMID: 32582546 Free PMC article.

8

γ-glutamyl transferase-to-platelet ratio based nomogram predicting overall survival of gallbladder carcinoma.

Sun LJ, Guan A, Xu WY, Liu MX, Yin HH, Jin B, Xu G, Xie FH, Xu HF, Du SD, Xu YY, Zhao HT, Lu X, Sang XT, Yang HY, Mao YL. Sun LJ, et al. World J Gastrointest Oncol. 2020 Sep 15;12(9):1014-1030. doi: 10.4251/wjgo.v12.i9.1014. World J Gastrointest Oncol. 2020. PMID: 33005295 Free PMC article.

9

Three-dimensional bio-printing of primary human hepatocellular carcinoma for personalized medicine.

Xie F, Sun L, Pang Y, Xu G, Jin B, Xu H, Lu X, Xu Y, Du S, Wang Y, Feng S, Sang X, Zhong S, Wang X, Sun W, Zhao H, Zhang H, Yang H, Huang P, Mao Y. Xie F, et al. Biomaterials. 2021 Jan;265:120416. doi: 10.1016/j.biomaterials.2020.120416. Epub 2020 Sep 22. Biomaterials. 2021. PMID: 33007612

10

Immunotherapy combination with regorafenib for refractory hepatocellular carcinoma: A real-world study.

Tu X, Yang J, Zheng Y, Liang C, Tao Q, Tang X, Liu Z, Jiang L, He Z, Xie F, Zheng Y. Tu X, et al. Among authors: xie f. Int Immunopharmacol. 2022 Dec;113(Pt B):109401. doi: 10.1016/j.intimp.2022.109401. Epub 2022 Nov 14. Int Immunopharmacol. 2022. PMID: 36395672

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,522 results

Search Page

Filters